Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 4Terminated 3Recruiting 2Not yet recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 93Lung Neoplasms 35Meningeal Carcinomatosis 11Neoplasms 10Neoplasm Metastasis 8Colorectal Neoplasms 6Adenocarcinoma of Lung 6Parkinson Disease 4, Autosomal Dominant Lewy Body 4Mesothelioma, Malignant 4Non-squamous Non-small Cell Lung Cancer 3NSCLC 3Mesothelioma 3Carcinoma 3Advanced Solid Tumors 3Pancreatic Neoplasms 2Non Squamous Non Small Cell Lung Cancer 2Neoplasms by Site 2Neoplasms by Histologic Type 2Endometrial Neoplasms 2Carcinoma, Bronchogenic 2Bronchial Neoplasms 2Breast Neoplasms 2Vaccinia 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Small Cell Lung Carcinoma 1Sexual Dysfunction, Physiological 1

Interventions

Gemcitabine 56130-nm albumin-bound paclitaxel 31Magnetic Resonance Spectroscopy 22Taxes 18Specimen Handling 18Albumin-Bound Paclitaxel 18Fluorouracil 17Drug Therapy 17Oxaliplatin 16Leucovorin 16pembrolizumab 15Irinotecan 14Biopsy 12Cyclophosphamide 11Blood Specimen Collection 11fludarabine 10Radiosurgery 9irinotecan sucrosofate 8Cetuximab 7olaparib 6folfirinox 6Magnetic Resonance Imaging 6Cisplatin 6Bevacizumab 6dehydroftorafur 5Surveys and Questionnaires 5Nivolumab 5Endoscopic Ultrasound-Guided Fine Needle Aspiration 5Capecitabine 5sintilimab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Pancreatic Neoplasms × Pemetrexed × Clear all
NCT07020221 2026-04-22

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Verastem, Inc.

Phase 1/2 Recruiting
295 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms

NCT04956640 2025-09-25

Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

Eli Lilly and Company

Phase 1/2 Recruiting
540 enrolled
GastrointestinalGynecologicThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡